Medical Education
View as webpage
Be The Match
HCT Update

Forward to a Colleague

Subscribe

FEATURE STORIES

ICD-10-PCS Coding Update Administration, Circulatory, Transfusion and HCT

Effective 10/1/2016, HCT Circulatory, Administration, and Transfusion ICD-10-PCS codes were updated to distinguish donor type. Highlights include:

bullet Transfusion code language updated from nonautologous to allogeneic
bullet Updated codes distinguish related, unrelated, and unspecified donors

Review replacement codes.

HCT RESEARCH

30% of Very Young HCT Recipients Experience One or More Late Effects

Vrooman LM, et al. Biol Blood Marrow Transplant This multi-center study showed that children under 3 years old who undergo HCT are at high risk for late effects. After 1 year, 30% had developed 1 or more organ toxicity or transplant-related complication. Read summary.

New Pre-HCT Counseling Recommendations to Preserve Fertility

Dalle J-H, et al. Bone Marrow Transplant In this report, a panel of transplant experts discuss state-of-the-art fertility preservation options available to adolescents and young adults who are considering hematopoietic cell transplantation (HCT). Read summary.

Education Opportunities

Advances in Blood and Marrow Transplantation for Sickle Cell Disease
Attend this webinar on September 27 to explore advances in BMT for treating patients with sickle cell disease, psychosocial and sociocultural and financial barriers to care, and interventions to address barriers to evidence-based care. This continuing education webinar is sponsored by NMDP/Be The Match and Sickle Transplant Alliance for Research (STAR). See full details and register.

On-demand webinar explores latest SCD treatment guidelines 
Mark C. Walters, M.D., Gregory J. Kato, M.D., Lakshmanan Krishnamurti, M.D., Marsha Treadwell, Ph.D., and Linda J. Burns, M.D, discuss new models for clinical decision-making in sickle cell disease (SCD), clinical trials, and strategies for overcoming barriers to patient care. Transplant recipient, Ines Lukombo, shares how she worked with her care team to choose HCT as a cure for her SCD. See full details and access activity.

Forward to a Friend

Please feel free to forward this email to others who would benefit from this information. If this email was forwarded to you, we invite you to subscribe.

If you have any questions or need additional information, please contact the Payer Policy Team at payerpolicy@nmdp.org.

All of our resources are available on our website: Payer.BeTheMatchClinical.org

National Marrow Donor Program, 500 N. 5th Street, Minneapolis, MN 55401
1 (763) 406-5800 | 1 (800) 526-7809 | Payer.BeTheMatchClinical.org | Privacy Policy | Terms of Use
Copyright © 2017 National Marrow Donor Program

This e-mail is sent only to individuals who have requested to receive E-communications from NMDP. If this email was forwarded to you, we invite you to subscribe.  If you would like to stop receiving education notices and our clinical e-newsletter, please unsubscribe.

Copyright © 1996-2018 National Marrow Donor Program. All Rights Reserved.